Women's Rogaine 5% Minoxidil Topical Aerosol Receives FDA Approval

November 4, 2014

The official launch to market of Women's Rogaine 5% Minoxidil Topical Aerosol, once-daily use treatment for Female Pattern Hair Loss containing 5 percent minoxidil in an elegant foam formula. Minoxidil is the only topical ingredient FDA-approved to help regrow hair.

Women's Rogaine 5% Minoxidil Topical Aerosol, penetrates into the scalp, with gentle massaging to reactivate hair follicles and stimulate hair regrowth. Clinical studies show that with once daily use of Women's Rogaine 5% Minoxidil Topical Aerosol for 24 weeks, 81 percent of women regrew hair, with initial results as early as 12 weeks and new hairs coming in up to 48 percent thicker than before.This innovation is a welcome solution to women looking for a proven solution to treat the condition rather than a cosmetic, quick fix.

Francine Wang, Senior Brand Manager, the Rogaine Brand said, "Hereditary hair loss is a complicated and emotional issue for women. Women crave solutions that work and can be easily incorporated into their daily beauty routines. Women's Rogaine 5% Minoxidil Topical Aerosol has convenient once-daily dosing and fits seamlessly into any beauty routine, akin to moisturizing or using an eye cream."

For more information go to: http://www.womensrogaine.com/.

Facebook Comments

Register

We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free